Products advertised online as compounded retatrutide should not automatically be assumed to be equivalent to the investigational product studied in registered clinical trials
Starting dose means modest medication effect
DOI: 10.1159/000341454 [Google Scholar] Xu WW, Guan MP, Zheng ZJ, Gao F, Zeng YM, Qin Y, et al
This indicates that G proteins have an intrinsic role in this process
In a post-hoc analysis of the published SURPASS trials, the change in systolic blood pressure was greater for tirzepatide versus the comparators of the trials (tirzepatide 5 mg: -5.1 to -1.3 mmHg, tirzepatide 10 mg: -6.5 to -1.7 mmHg, tirzepatide 15 mg: -11.5 to -3.1 mmHg) [65]
But the peptide is pharmacologically inactive